Proposed sale of 717,688 common shares

Proposed sale of common stock by a holder via Form 144.

Rhea-AI Filing Summary

Proposed sale of common stock by a holder via Form 144. The filing lists 717,688 common shares associated with an exercise of options under a registered plan with an indicated trade date of 05/11/2026. The sales method is listed as cash.

Key Figures

Shares proposed for sale: 717,688 shares Transaction date: 05/11/2026 Sale method: Cash

3 metrics

Shares proposed for sale 717,688 shares listed under "Securities To Be Sold"

Transaction date 05/11/2026 date shown with securities to be sold

Sale method Cash listed as the sale consideration/method

Key Terms

Form 144, exercise of options under a registered plan, cash

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

exercise of options under a registered plan financial

"Securities To Be Sold | Exercise of options under a registered plan"

cash financial

"Securities To Be Sold | ... | Cash"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AUPH Form 144 report?

The Form 144 reports a proposed transaction of 717,688 common shares tied to the exercise of options under a registered plan, with an indicated date of 05/11/2026 and a cash sale method.

Does the Form 144 show who will receive proceeds for AUPH?

The excerpt specifies the sale method as cash and lists the seller action as an exercise of options under a registered plan. The filing does not state the ultimate recipient of proceeds beyond this cash sale designation.

When is the proposed sale date listed on the AUPH notice?

The filing shows an indicated date of 05/11/2026 alongside the securities to be sold. The entry ties that date to the exercise of options under a registered plan and the listed quantity of 717,688 shares.

How many shares are proposed for sale in the AUPH Form 144?

The Form 144 lists 717,688 common shares in the securities-to-be-sold section. The filing links that quantity to an exercise of options under a registered plan with a cash disposition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:10 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001636642
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AURINIA PHARMACEUTICALS INC.
SEC File Number	001-36421
Address of Issuer	#140, 14315 - 118 AVENUE EDMONTON ALBERTA, CANADA T5L 4S6
Phone	250-744-2487
Name of Person for Whose Account the Securities are To Be Sold	MATTHEW MAXWELL DONLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	717688	11368177.92	128601671	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/11/2026	Exercise of options under a registered plan	Issuer			717688	05/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This Form 144 is being filed for the cashless exercise of options and subsequent sales of the underlying shares commencing on 05/11/2026
Date of Notice	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Matthew Maxwell Donley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)